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Abstract Biotin synthase (BioB) is a member of a family of
enzymes that includes anaerobic ribonucleotide reductase and
pyruvate formate lyase activating enzyme. These enzymes all use
S-adenosylmethionine during turnover and contain three highly
conserved cysteine residues that may act as ligands to an iron-
sulfur cluster required for activity. Three mutant enzymes of
BioB have been made, each with one cysteine residue (C53, 57,
60) mutated to alanine. All three mutant enzymes were inactive,
but they still exhibited the characteristic UV-visible spectrum of
a [2Fe-2S]2+ cluster similar to that of the wild-type enzyme.
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1. Introduction
Biotin synthase (BioB) participates in the ¢nal step of the
biotin biosynthetic pathway, where a sulfur atom is inserted
between the unactivated methyl and C6 methylene group of
dethiobiotin (Fig. 1). Catalytic activity in vitro has not been
observed for this reaction [1^3].
BioB is a homodimeric protein with a subunit molecular
mass of 38.7 kDa and contains an iron-sulfur (Fe-S) cluster
that has been the focus of recent investigations. Using spec-
troscopic techniques [4,5], the near stoichiometric conversion
of two [2Fe-2S]2 clusters (one per monomer of BioB) to form
a single [4Fe-4S]2 cluster has been observed. As no exoge-
nous iron or sul¢de had been added, it was postulated that the
[4Fe-4S]2 cluster formed a bridge between the two monomers
of BioB and was the active form [4]. A similar essential Fe-S
cluster has also been proposed for pyruvate formate lyase
activating enzyme (p£ AE) [6] and anaerobic ribonucleotide
reductase activating enzyme (aRR AE) [7]. However, aRR AE
has subsequently been shown to assemble one [4Fe-4S] cluster
per monomer (under strictly anaerobic conditions) and this is
thought to be the active species under assay conditions [8].
Ku«lzer et al. [9] have recently demonstrated that active p£ AE
can also be reconstituted under anaerobic conditions, as a
monomeric (28 kDa) holoenzyme with one [4Fe-4S] cluster
per monomer. There is a high degree of sequence similarity
between aRR AE, p£ AE and BioB, in particular a highly
conserved cysteine triad (C-X3-C-X2-C) that seems likely to
be a ligand to the Fe-S cluster [4] (Fig. 2).
All these enzymes share a common co-factor requirement
for S-adenosylmethionine (SAM) and for a reducing system
consisting of NADPH, ferredoxin (£avodoxin) NADP re-
ductase and £avodoxin [3,6,10]. For all three enzymes, the
proposed role of the [4Fe-4S]2 cluster is the one electron
reductive cleavage of SAM to methionine and a 5P-deoxyade-
nosyl radical. This radical may react further, either to form a
carbon-centred protein radical as proposed for the mechanism
of p£ AE and aRR AE [5], or directly with the substrate, as
suggested for BioB [11].
The key functional di¡erence between BioB and p£/aRR
AE is that the Fe-S cluster of BioB may also serve as the
immediate sulfur atom donor during biotin formation [12].
The Fe-S cluster of BioB is therefore bifunctional.
In view of the importance of the Fe-S cluster of BioB, three
mutant enzymes were made. Each had one of the cysteine
residues of the cysteine triad mutated to alanine and the e¡ect
on the spectroscopic properties and activity of BioB was ob-
served.
2. Materials and methods
2.1. Materials
DNA manipulations were carried out by standard protocols [13].
All chemicals were of reagent grade and obtained from Sigma^Aldrich
Chemical Co. unless otherwise stated. Restriction enzymes and mo-
lecular biology reagents were purchased from Promega. Oligonucleo-
tides were synthesised by Mrs V. Cooper, Dyson Perrins Laboratory,
Oxford University, on an Applied Biosystems DNA Synthesiser (mod-
el 380B or 394). Protein concentrations were determined by the meth-
od of Bradford [14]. [14C]Dethiobiotin (100 WCi/mmol) was synthe-
sised enzymatically [15].
2.2. Site-directed mutagenesis
The bioB gene was ampli¢ed by PCR and ligated into the p-GEM T
vector. We have found that the BioB gene product contains two
mutations which may have been introduced during the PCR ampli¢-
cation. At position 12, a valine (GTC) is mutated to an alanine (GCC)
and at position 335, a proline (CCG) is mutated to a leucine (CTG).
The enzyme retained the same activity as literature reports. Single-
stranded DNA was produced by standard techniques using helper
phage R408. Site-directed mutagenesis was performed using the
U.S.E. Mutagenesis kit (Amersham Pharmacia Biotech). In this tech-
nique, one primer, the target primer, introduces the desired mutation
into the plasmid DNA. The other, the selection primer, mutates a
unique non-essential restriction site which serves as a basis for selec-
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tion of mutated plasmids. Each of the cysteines from the sequence,
ACPEDCKYCP, was mutated individually to give three mutant en-
zymes, each with one cysteine to alanine mutation: target primer, ¢rst
cysteine, C53A: 5P-GCA ATC TTC CGG AGC AGC TCC GG-3P.
Target primer, second cysteine, C57A: 5P-CGG GCA GTA TTT
AGC ATC TTC CGG-3P. Target primer, third cysteine, C60A: 5P-
GCG CGA GCT TTG CGG AGC GTA TTT GC-3P (mutations are
underlined).
Positive mutants, as shown by restriction digest, were con¢rmed by
DNA sequencing.
2.3. Expression and puri¢cation
For expression studies, the wild-type and mutant bioB genes were
subcloned into the pET 24d(+) vector (Novagen) after digestion of the
p-GEM T vector with NcoI/BamHI restriction enzymes.
Plasmids were transformed into BL21(DE3) and grown at 37‡C
in 2TY media containing 30 Wg/ml kanamycin. When the OD600
reached 1.0, the temperature was reduced to 30‡C, the cells were
induced with 0.5 mM isopropyl-L-D-thiogalactoside and harvested
after 2.5 h by centrifugation in a JA-14 rotor at 12 000 rpm for 30
min at 4‡C.
BioB/BL21(DE3) cells were thawed and resuspended in 50 mM
Tris^HCl, pH 7.5, 1 mM dithiothreitol (DTT). Chicken egg white
lysozyme was added (0.5 mg/ml), the mixture stirred for 15 min and
Triton X-100 added to 1% (w/v). After a further 15 min stirring, the
cell debris was removed by centrifugation in a JA-14 rotor at 12 000
rpm for 30 min at 4‡C. Ammonium sulfate was added to 35% satu-
ration and the centrifugation repeated. The resulting pellet was resus-
pended in bu¡er A (50 mM Tris^HCl, pH 7.5) and an equal volume
of bu¡er B added (50 mM Tris^HCl, pH 7.5, 0.5 M (NH4)2SO4). This
was loaded onto a Source Phe column (Pharmacia, 150 ml) that
had been equilibrated with bu¡er B, and protein was eluted with a
0^100% gradient of bu¡er A. The purest samples, as judged by so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) analysis, were combined, concentrated to 50 mg/ml and chro-
matographed on a Superdex-S200 column (Pharmacia, 700 ml) that
had been equilibrated with bu¡er A. The purest fractions, s 95%
pure by SDS^PAGE analysis, were combined and concentrated to
50 mg/ml and stored at 380‡C. The mutant proteins were puri¢ed
in a similar way.
2.4. Enzyme assays
Assays of either wild-type or mutant BioB were performed by the
method of Birch et al. [3], including co-factor requirements, incuba-
tion time and isolation of biotin. Lysate assays included 2.25 mg of
BioB containing lysate supplemented with a further 2.25 mg of
BL21(DE3) cell free extract. The wild-type enzyme produced 2.6
nmol of biotin (0.44 mol of biotin per mol of BioB over a 1 h assay,
assuming a 10% expression level).
Puri¢ed BioB, either wild-type or mutant, was assayed using 0.225
mg of puri¢ed bioB and supplemented with BL21(DE3) cell free lysate
to bring the total protein content to 4.5 mg. The wild-type enzyme
produced 3.18 nmol of biotin (0.54 mol of biotin per mol of BioB over
a 1 h assay).
2.5. Iron quanti¢cation
Iron content was measured using both inductively coupled plasma
optical emission spectroscopy on a Jobin-Yvon 36 spectrometer at
259.4 nm and the method of Fish [16].
2.6. Spectroscopy
UV-visible absorbance spectra were measured over the scan range
200^800 nm using a Shimadzu UV-1601 spectrophotometer at protein
concentrations of 3.0 mg/ml in 50 mM Tris^HCl bu¡er, pH 7.5. CD
spectra were recorded using a Jasco 720 spectropolarimeter at 20‡C in
a 1 mm path length cell over the range 190^250 nm at a protein
concentration of 0.2 mg/ml in 10 mM Tris^HCl bu¡er, pH 7.5.
3. Results
3.1. Expression and puri¢cation
BioB was overexpressed in Escherichia coli BL21(DE3) as
approximately 10% of the total soluble protein, as judged by
SDS^PAGE analysis, and was the most abundant band.
Growth of cells containing the mutant proteins C53A, C57A
and C60A gave comparable levels of expression (Fig. 3). The
mutant proteins exhibited similar chromatographic properties
as the wild-type enzyme during puri¢cation, having similar
elution pro¢les from the Source Phe and Superdex-S200 col-
umns. Puri¢cation of the wild-type and mutant enzymes gave
samples of s 95% purity, as judged by SDS^PAGE analysis,
that were suitable both for assays and for spectroscopy. BioB
is reddish brown due to the presence of the Fe-S cluster. The
mutant proteins were of a similar, but less intense colour than
the wild-type, suggesting that some form of Fe-S cluster re-
mained. This was further investigated by spectroscopic tech-
niques.
3.2. Spectroscopy and iron quanti¢cation
The UV-visible absorption spectrum of the wild-type BioB
was consistent with the presence of a [2Fe-2S]2 cluster, with
absorbance maxima at 330 and 420 nm, as previously ob-
served [4]. The mutant enzymes exhibited spectra with an
identical form, but with a decrease in the extinction coe⁄-
cients over the wavelengths scanned (Fig. 4). Iron quanti¢ca-
tion by either method indicated that for the wild-type, and the
mutant enzymes, the iron content was lower than if each
monomer bound two atoms of iron, as expected. However,
for the mutant enzymes C53A and C57A, the iron content
Fig. 1. The conversion of dethiobiotin to biotin.
Fig. 2. The conserved cysteine triad motif from BioB, p£ AE and
aRR AE.
Fig. 3. Coomassie blue-stained 12.5% SDS^PAGE gel of wild-type
and mutant BioB cell lysates and puri¢ed enzyme. Each lane was
loaded with 15 Wg of protein. (1) Molecular weight markers, 94, 67,
43, 30, 20.1 and 14.4 kDa; (2) wild-type; (3) C53A; (4) C57A; (5)
C60A cell lysates; (6) wild-type; (7) C53A; (8) C57A; (9) C60A pu-
ri¢ed enzymes.
FEBS 23249 21-1-00
K.S. Hewitson et al./FEBS Letters 466 (2000) 372^376 373
was approximately half that of the wild-type enzyme (Table 1),
and for C60A, there was slightly more iron present than in the
other mutant enzymes. These values are re£ected in the UV-
visible absorption spectra. Comparison of the CD spectra of
the wild-type and the mutant enzymes indicated no signi¢cant
secondary structure alteration (data not shown).
3.3. Radiochemical assays
All three mutant enzymes were inactive when assayed in cell
lysates, in direct comparison with the wild-type enzyme (Fig.
5). The puri¢ed wild-type and mutant enzymes were all inac-
tive when assayed in isolation without the other proteins nec-
essary for BioB activity [3]. However, upon addition of E. coli
BL21(DE3) cell lysate, which contains these additional pro-
teins, activity was restored to the wild-type puri¢ed enzyme,
but not for the mutant enzymes.
4. Discussion
This is the ¢rst experimental evidence that BioB cysteine
residues C53, C57 and C60 are essential for activity and is
consistent with their proposed role as ligands to the Fe-S
cluster.
UV-visible spectroscopy and iron quanti¢cation suggested
incomplete formation of the [2Fe-2S]2 cluster upon replace-
ment of a single cysteine with alanine. The low iron content
for both wild-type and mutant enzymes was probably due to
cluster degradation during aerobic puri¢cation. Cluster degra-
dation has been observed for aRR AE [17], where there was a
direct correlation between activity and iron content. Imple-
mentation of anaerobic puri¢cation procedures may be re-
quired to reduce such iron loss.
Although reconstitution of the BioB Fe-S cluster by Tse
Sum Bum et al. [11] demonstrated that the Fe-S cluster was
the immediate sulfur donor to dethiobiotin, it did not result in
catalytic activity in vitro. To explain this, it was suggested
that regeneration of the intact Fe-S cluster was a pre-requisite
for multiple turnovers. The mechanism of Fe-S cluster forma-
tion or regeneration in vivo is still unknown. Several gene
products, e.g. from the isc gene cluster, may be involved
[18^20].
Resonance Raman [4] and Mo«ssbauer studies [5] are con-
sistent with incomplete cysteinyl co-ordination of the
[2Fe-2S]2 cluster, with an oxygenic ligand, possibly serine,
functioning as the fourth cluster ligand. A mechanism has
been proposed for the reductive dimerisation of two such
[2Fe-2S]2 clusters to form a single [4Fe-4S]2 cluster bridging
Fig. 4. Comparison of the UV-visible spectra of the wild-type BioB and the cysteine mutant enzymes at 3.0 mg/ml. From top to bottom trace,
wild-type, C60A, C53A, C57A.
Table 1
Comparison of the iron content of the wild-type and BioB mutants,
C53A, C57A and C60A
Protein Iron quanti¢cation (mol Fe/mol bioB) by method:
1 2
Wild-type 0.39 0.33
C53A 0.23 0.17
C57A 0.21 0.17
C60A 0.28 0.22
Method 1: inductively coupled plasma optical emission spectros-
copy, method 2: Fish [16].
Fig. 5. Results of radiochemical assay with cell lysates. (1)
[14C]Dethiobiotin; (2) wild-type; (3) C53A; (4) C57A; (5) C60A.
Radiolabelled compounds were analysed by thin layer chromatogra-
phy and autoradiography. The wild-type enzyme (2) showed a
14C-labelled compound with the same RF value as biotin.
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the monomers of BioB (Fig. 6). This mechanism results in
displacement of the oxygenic ligand upon [4Fe-4S]2 cluster
formation. The [4Fe-4S]2 cluster is proposed to be the form
of BioB involved in catalysis [4]. It seems reasonable to sug-
gest that the mutants described here are unable to undergo
this rearrangement and are therefore also unable to partici-
pate in the conversion of dethiobiotin to biotin. Work is in
progress to elucidate the exact form of the Fe-S cluster in the
mutant proteins and the nature of the fourth cluster binding
ligand.
It is possible that a spatially close alternative residue is
acting as a ligand to the Fe-S cluster, as a substitute for the
mutated cysteine, and there are a total of eight cysteine resi-
dues in BioB. This phenomenon has been observed for Azo-
tobacter vinelandii ferredoxin I [21], which binds one [4Fe-4S]
and one [3Fe-3S] cluster per monomer. This ferredoxin has
C20 as the distant ligand to the [4Fe-4S] cluster which, upon
mutation to an alanine, still binds a [4Fe-4S] cluster. Struc-
tural rearrangement of the protein, as determined by X-ray
crystallography, allowed a ‘free cysteine’, C24, to replace C20
as a cluster binding ligand.
Mutagenesis of cysteinyl Fe-S cluster binding ligands to
serine residues has also been reported. Ku«lzer et al. [17]
have mutated all of the cysteine residues in p£ AE to serines.
They observed that three out of the six cysteine residues were
essential for activity which in a sequence alignment are equiv-
alent to C53, C57 and C60 of BioB. In studies on other pro-
teins, the mutagenesis resulted in an Fe-S cluster similar to
that of the wild-type protein that could support biological
activity ([22] and references therein). There are also naturally
occurring proteins that contain non-cysteinyl ligands to Fe-S
clusters. Pyrococcus furiosus ferredoxin, which contains a sin-
gle [4Fe-4S] cluster, possesses three cysteine residues with an
aspartate as the fourth cluster binding ligand [23]. Rieske
[2Fe-2S] clusters have two cysteines and two histidines as their
binding ligands [24]. One aspartate and two serine residues are
close to the cysteine triad in the E. coli BioB sequence, AC-
PEDCKYCPQSS. It is therefore possible that one of these
residues could substitute for a mutated cysteine, but it is un-
clear if such a rearrangement would be observed by CD spec-
troscopy. The X-ray crystal structure of BioB has not yet been
reported and hence investigation by this method is not possi-
ble.
Fe-S cluster enzymes are widespread in biology and func-
tion primarily as electron transporters with the ferredoxins
([25] and references therein). Fe-S cluster enzymes are directly
involved in enzyme catalysis, e.g. conversion of citrate to iso-
citrate by aconitase [26], and both SoxR [27] and fumarate
nitrate reduction protein (FNR) [28] are proposed to have
roles in transcriptional regulation. Exposure of E. coli FNR
protein to oxygen converts the regulatory [4Fe-4S]2 cluster to
a single [2Fe-2S]2. Reconstitution of the active FNR form
requires incubation with cysteine, iron, DTT and the NifS
protein. The ¢rst three of these are required as co-factors
for the in vitro BioB assay.
The Fe-S cluster of BioB is required not only as the electron
donor to SAM, but also as the sulfur donor to dethiobiotin.
The apparent interconversion between the two di¡erent clus-
ter forms, [2Fe-2S] and [4Fe-4S], may also be necessary for
the function of BioB. Further mutagenesis investigations will
provide additional information on the role of the Fe-S cluster
in the formation of biotin.
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